204 related articles for article (PubMed ID: 29528145)
1. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
2. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
Dimri M; Kang M; Dimri GP
Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
[TBL] [Abstract][Full Text] [Related]
3. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
Dimri M; Cho JH; Kang M; Dimri GP
J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.
Cho JH; Dimri M; Dimri GP
J Biol Chem; 2015 Apr; 290(16):10555-67. PubMed ID: 25737447
[TBL] [Abstract][Full Text] [Related]
5. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
[TBL] [Abstract][Full Text] [Related]
6. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
7. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
[TBL] [Abstract][Full Text] [Related]
8. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
[TBL] [Abstract][Full Text] [Related]
9. microRNA-141 regulates BMI1 expression and induces senescence in human diploid fibroblasts.
Dimri M; Carroll JD; Cho JH; Dimri GP
Cell Cycle; 2013 Nov; 12(22):3537-46. PubMed ID: 24091627
[TBL] [Abstract][Full Text] [Related]
10. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
M JR; S V
Gene; 2018 Dec; 678():302-311. PubMed ID: 30096458
[TBL] [Abstract][Full Text] [Related]
11. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
[TBL] [Abstract][Full Text] [Related]
12. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-7 inhibits multiple oncogenic pathways to suppress HER2Δ16 mediated breast tumorigenesis and reverse trastuzumab resistance.
Huynh FC; Jones FE
PLoS One; 2014; 9(12):e114419. PubMed ID: 25532106
[TBL] [Abstract][Full Text] [Related]
14. Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer.
Ojo D; Lin X; Wu Y; Cockburn J; Bane A; Tang D
Cancer Lett; 2018 Jul; 426():4-13. PubMed ID: 29626519
[TBL] [Abstract][Full Text] [Related]
15. A positive feedback loop regulates the expression of polycomb group protein BMI1 via WNT signaling pathway.
Cho JH; Dimri M; Dimri GP
J Biol Chem; 2013 Feb; 288(5):3406-18. PubMed ID: 23239878
[TBL] [Abstract][Full Text] [Related]
16. Amplification of hsa-miR-191/425 locus promotes breast cancer proliferation and metastasis by targeting DICER1.
Zhang X; Wu M; Chong QY; Zhang W; Qian P; Yan H; Qian W; Zhang M; Lobie PE; Zhu T
Carcinogenesis; 2018 Dec; 39(12):1506-1516. PubMed ID: 30084985
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C
Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065
[TBL] [Abstract][Full Text] [Related]
18. BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.
Zhang XW; Sheng YP; Li Q; Qin W; Lu YW; Cheng YF; Liu BY; Zhang FC; Li J; Dimri GP; Guo WJ
Mol Cancer; 2010 Feb; 9():40. PubMed ID: 20170541
[TBL] [Abstract][Full Text] [Related]
19. CBX4 exhibits oncogenic activities in breast cancer via Notch1 signaling.
Zeng JS; Zhang ZD; Pei L; Bai ZZ; Yang Y; Yang H; Tian QH
Int J Biochem Cell Biol; 2018 Feb; 95():1-8. PubMed ID: 29229426
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
Gong XF; Yu AL; Tang J; Wang CL; He JR; Chen GQ; Zhao Q; He M; Zhou CX
Exp Cell Res; 2018 Jan; 362(2):378-385. PubMed ID: 29208462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
